Clinical Trial Update: Palbociclib and Dexamethasone in Treating Participants With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia [Phase 1]

View source ↗

Summary

This Phase 1 trial update reports completion of a study evaluating the combination of palbociclib and dexamethasone in relapsed or refractory B-cell acute lymph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Palbociclib (palbociclib)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Conditions: Recurrent B Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia | Phase 1 | Status: COMPLETED